The commercialization of patient data in Canada: ethics, privacy and policy
Sheryl Spithoff, Jessica Stockdale, Robyn Rowe, Brenda McPhail, Nav Persaud
Abstract
KEY POINTS In Canada, commercial data brokers are currently able to use deidentified patient data from pharmacies, private drug insurers, the federal government and medical clinics without patient consent. They are able to do this because of a lack of privacy protections for deidentified data. A
Topics & Concepts
Patient privacyGovernment (linguistics)CommercializationPharmacyData anonymizationPatient dataInformation privacyInternet privacyPrivacy lawInformed consentPrivacy policyMedicineData scienceComputer scienceFamily medicineBusinessAlternative medicineHealth carePolitical scienceMarketingPhilosophyLawLinguisticsPathologyEthics in Clinical ResearchPharmaceutical industry and healthcareElectronic Health Records Systems